Grifols SA, a Spanish drugmaker, is negotiating with banks to refinance €1.4 billion in bonds and credit lines, aiming to address investor concerns about meeting obligations. Despite challenges, the company remains optimistic about securing bank support.
Read MoreDid you find this insightful?
Bad
Just Okay
Amazing